Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R. Wolfe, Anabela Cardoso, Vincent C. Marconi et al.|The Lancet Respiratory Medicine|2022Cited by 128
Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesisChang Kyung Kang, Inkyung Jung, Baekgyu Choi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1